John W. Brooker & Co’s BioNTech BNTX Stock Holding History

John W. Brooker & Co’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300	Closed	-$33K	–	190
2021 Q1	$33K	Buy	+300	New	+$31.9K	0.02%	84

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

John W. Brooker & Co's BNTX Position: Q2 2021 in Review

John W. Brooker & Co sold out of BioNTech (BNTX) in Q2 2021, closing a stake of 300 shares — an estimated $33K sold.

John W. Brooker & Co first reported a position in BNTX in Q1 2021 and held it in 1 quarter. The position peaked at $33K in Q1 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2021.

John W. Brooker & Co reported no remaining BioNTech position as of Q2 2021 after selling out during the quarter.
John W. Brooker & Co sold 300 BioNTech shares in Q2 2021, an estimated $33K.
John W. Brooker & Co first reported a position in BioNTech in Q1 2021 and held it in 1 quarter.
John W. Brooker & Co's BioNTech position peaked at $33K in Q1 2021.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2021.

Based on John W. Brooker & Co's 13F filing for Q2 2021, filed 9 Jul 2021.